ALTME — TME Pharma NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for TME Pharma NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1.41	10.3	9.48	4.63	2.25
Net Total Receivables	0.079	0.069	0.081	0.279	0.041
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1.58	10.5	9.69	5.01	2.39
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.142	0.118	0.066	0.221	0.096
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1.73	10.7	9.77	5.24	2.49
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.5	2.9	5.27	6.45	2.79
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	3.58	2.94	5.25	6.51	2.79
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-1.84	7.71	4.51	-1.27	-0.294
Total Liabilities & Shareholders' Equity	1.73	10.7	9.77	5.24	2.49
Total Common Shares Outstanding